Skip to main content
Clinical Trials/NCT05397418
NCT05397418
Completed
Not Applicable

Effectiveness of a 12-week Low Impact Resistance Training Programme on Muscle Function, Body Composition, Quality of Life and Muscle Protein Synthesis in Women Aged 40-60 Years

University of Exeter1 site in 1 country72 target enrollmentMay 1, 2022
ConditionsMuscle Function

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Muscle Function
Sponsor
University of Exeter
Enrollment
72
Locations
1
Primary Endpoint
Muscle function
Status
Completed
Last Updated
last year

Overview

Brief Summary

Participating in regular physical activity has been shown to reduce the risk of developing some diseases and disabilities that can occur with ageing. Muscles naturally decline with age, and in females this appears to occur more so around the time of menopause. Time, work, family commitments and the availability of facilities have all been identified as barriers to exercise in middle age.

Increasing activity levels in middle age appears to improve muscle function and bone health. However, there is a lack of evidence in how muscle function responds to low impact resistance exercise in middle aged females.

This study aims to assess the effectiveness and the mechanisms associated with building muscle as well as the effect on quality of life in middle aged (40-60 years) females using a low impact resistance training programme.

Registry
clinicaltrials.gov
Start Date
May 1, 2022
End Date
November 23, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Females aged 40-60 years of age at time of screening.
  • Body mass index \<30kg/m2 and \>18.5kg/m2
  • Considered moderately active according to the 7 day International Physical Activity Questionnaire (IPAQ) (Craig et al., 2003)
  • Self-reported as healthy (absence of injury or disease).
  • Availability and willingness to attended 12 weeks of exercises classes 4-5 times per week at St Luke's Campus Exeter and participate in the study lasting a total of 26 weeks.

Exclusion Criteria

  • Pregnant, lactating or planning a pregnancy.
  • Current diagnosis of a chronic disease such as diabetes, autoimmune disease, cardiovascular disease, kidney disease.
  • Hysterectomy and/or ovariectomy.
  • Currently prescribed hormone replacement therapy.
  • Hypertension (BP ≥149/90 mm/Hg)
  • Either current smoker, or history of smoking in the past 6 months.
  • Currently taking supplements that have been shown to impact muscle function and muscle mass, such as creatine, in the last 6 months.
  • Prescribed medications that have been shown to impact muscle function and muscle mass, such as steroids, in the last 6 months.
  • History of epilepsy.
  • Current or recent injury within the last 6 months that may affect their ability to carry out the resistance training program.

Outcomes

Primary Outcomes

Muscle function

Time Frame: 12 weeks

Peak torque (Nm) of the shoulder and hip

Secondary Outcomes

  • Changes in flexibility(12 weeks)
  • Muscle protein synthesis(12 weeks)
  • Energy expenditure(12 weeks)
  • Bone mineral density(12 weeks)
  • Physical activity levels(12 weeks)
  • Exercise program acceptability(12 weeks)
  • Changes in balance(12 weeks)
  • Changes in diabetes risk markers(12 weeks)
  • Body composition(12 weeks)
  • Sleep Quality(12 weeks)
  • Self reported quality of life(12 weeks)
  • Muscle thickness(12 weeks)
  • Changes in cardiovascular risk markers(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials